Drug Procurement Cooperation (LIS) - Norwegian Tender System to Reduce Cost of Expensive Medicines

• Autorzy: Paweł Mielnik
• Języki publikacji: EN

Abstrakty

EN

The article describes functioning of drug procurement cooperation. A Norwegian organisation which main goal is to reduce costs of expensive treatments(original abstract)

Słowa kluczowe

EN

Expenditures on health care; Medications

PL

Wydatki na ochronę zdrowia; Leki

• Czasopismo: Journal of Health Policy and Outcomes Research
• Rocznik: 2014
• Numer: nr 1
• Strony: 18--31

Twórcy

autor

Paweł Mielnik

• Section for Rheumatology, Department of Neurology,Rheumatology, and Physical Medicine, Førde Central Hospital, Førde, Norway

Bibliografia

• Smolen JS., Landewé R., Breedveld FC., et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis 2013; 0:1-18
• Available from: www.lisnorway.no;
• Røed Dahl S., Manavado L., Monsen Ø., Siem H., et al. Norway and Health. An introduction. Apr 2009. Booklet of Norwegian Directorate of Health
• Available from: www.lisnorway.no; LIS-TNF/BIO Avtaler 2014
• Sparte 168 millioner på samarbeid om legemiddelinnkjøp i Hele Midt-Norge. 2014 [Cited 18.04.2014] From http://www.sykehusapoteket.no/no/Aktuelt/Aktuelt-fra-Sykehusapoteket/Sparte-168-millioner-pa-samarbeid-om-legemiddelinnkjop-i-Helse-Midt-Norge/122274/;
• European Medicines Agency. Guideline on similar biological medicinal products. Oct 2005

Identyfikatory

DOI

10.7365/JHPOR.2014.5.6